Investigating efficacy of “microbiota modulation of the gut-lung Axis” combined with chemotherapy in patients with advanced NSCLC: study protocol for a multicenter, prospective, double blind, placebo controlled, randomized trial

BACKGROUND: Most NSCLCs metastasised out of the lungs at the time of diagnosis and cannot be surgically removed . Cytotoxic chemotherapy drugs have become the main treatment in recent decades, especially in patients with NSCLC without EGFR, ALK, and ROS gene mutations. The prognosis of lung cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Qing, Chen, Guojie, Ren, Yanbei, Zheng, Tiansheng, Shen, Changxing, Li, Ming, Chen, Xiangyun, Zhai, Hong, Li, Zhuang, Xu, Jianfang, Gu, Aiqin, Jin, Meiling, Fan, Lihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220724/
https://www.ncbi.nlm.nih.gov/pubmed/34157996
http://dx.doi.org/10.1186/s12885-021-08448-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220724/
https://www.ncbi.nlm.nih.gov/pubmed/34157996
http://dx.doi.org/10.1186/s12885-021-08448-6

Ejemplares similares